Abstract
Background
Pelvic exenteration remains one of the most mutilating procedures, with important postoperative morbidity, an altered body image, and long-term physical and psychosocial concerns. This study aimed to assess quality of life (QOL) during the first year after pelvic exenteration for gynecologic malignancy performed with curative intent.
Methods
A French multicentric prospective study was performed by including patients who underwent pelvic exenteration. Quality of life by measurement of functional and symptom scales was assessed using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 (version 3.0) and the EORTC QLQ-OV28 questionnaires before surgery, at baseline, and 1, 3, 6, and 12 months after the procedure.
Results
The study enrolled 97 patients. Quality of life including physical, personal, fatigue, and anorexia reported in the QLQ-C30 was significantly reduced 1 month postoperatively and improved at least to baseline level 1 year after the procedure. Body image also was significantly reduced 1 month postoperatively. Global health, emotional, dyspnea, and anorexia items were significantly improved 1 year after surgery compared with baseline values. Unlike younger patients, elderly patients did not regain physical and social activities after pelvic exenteration.
Conclusions
Therapeutic decision on performing a pelvic exenteration can have a severe and permanent impact on all aspects of patients’ QOL. Deterioration of QOL was most significant during the first 3 months after surgery. Elderly patients were the only group of patients with permanent decreased physical and social function. Preoperative evaluation and postoperative follow-up evaluation should include health-related QOL instruments, counseling by a multidisciplinary team to cover all aspects concerning stoma care, sexual function, and long-term concerns after surgery.
Similar content being viewed by others
References
Marnitz S, Köhler C, Müller M, Behrens K, Hasenbein K, Schneider A. Indications for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol. 2006;103:1023–30.
Maggioni A, Roviglione G, Landoni F, et al. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol. 2009;114:64–6.
Ungar L, Palafavi L, Novak Z. Primary pelvic exenteration in cervical cancer patients. Gynecol Oncol. 2008;111:S9–12.
Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, et al. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol. 2014;134:546–51.
Chiva LM, Lapuente F, González-Cortijo L, González-Martín A, Rojo A, García JF, Carballo N. Surgical treatment of recurrent cervical cancer: state of the art and new achievements. Gynecol Oncol. 2008;110(3 Suppl 2):S60–6.
Ferron G, Gangloff D, Querleu D, Frigenza M, Torrent JJ, Picaud L, et al. Vaginal reconstruction with pedicled vertical deep inferior epigastric perforator flap (DIEP) after pelvic exenteration: a consecutive case series. Gynecol Oncol. 2015;138:603–8.
Jurado M, Bazán A, Alcázar JL, Garcia-Tutor E. Primary vaginal reconstruction at the time of pelvic exenteration for gynecologic cancer: morbidity revisited. Ann Surg Oncol. 2009;16:121–7.
Harji DP, Griffiths B, Velikova G, Sagar PM, Brown J. Systematic review of health-related quality of life in patients undergoing pelvic exenteration. Eur J Surg Oncol. 2016;42:1132–45.
Rezk YA, Hurley KE, Carter J, Dao F, Bochner BH, Aubey JJ, et al. A prospective study of quality of life in patients undergoing pelvic exenteration: interim results. Gynecol Oncol. 2013;128:191–7.
Martinez A, Filleron T, Vitse L, et al. Laparoscopic pelvic exenteration for gynaecological malignancy: is there any advantage? Gynecol Oncol. 2011;120:374–9.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.
Cull A, Howat S, Greimel E, et al. Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report. Eur J Cancer. 2001;37:47–53.
Greimel E, Bottomley A, Cull A, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer. 2003;39:1402–8.
Magrina JF. Types of pelvic exenterations: a reappraisal. Gynecol Oncol. 1990;37:363–6.
Höckel M. Laterally extended endopelvic resection (LEER): principles and practice. Gynecol Oncol. 2008;111:S13–7
Hawighorst-Knapstein S, Fusshoeller C, Franz C, Trautmann K, et al. The impact of treatment for genital cancer on quality of life and body image: results of a prospective longitudinal 10-year study. Gynecol Oncol. 2004;94:398–403.
Roos EJ, de Graeff A, van Eijkeren MA, et al. Quality of life after pelvic exenteration. Gynecol Oncol. 2004;93:610–14.
Vera MI. Quality of life following pelvic exenteration. Gynecol Oncol. 1981;12:355–66.
Breetvelt IS, Van Dam FS. Underreporting by cancer patients: the case of response-shift. Soc Sci Med. 1991;32:981–7.
Esnaola NF, Cantor SB, Johnson ML, et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol. 2002;20:4361–7.
Young JM, Badgery-Parker T, Masya LM, King M, Koh C, Lynch AC, et al. Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy. Br J Surg. 2014;101:277–87.
Austin KK, Young JM, Solomon MJ. Quality of life of survivors after pelvic exenteration for rectal cancer. Dis Colon Rectum. 2010;53:1121–6.
Dale W, Hemmerich J, Kamm A, Posner MC, Matthews JB, Rothman R, et al. Geriatric assessment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy: a prospective cohort study. Ann Surg. 2014;259:960–5.
Dessole M, Petrillo M, Lucidi A, et al. Quality of life in women after pelvic exenteration for gynecological malignancies: a multicentric study. Int J Gynecol Cancer. 2016. https:doi.org/10.1097/IGC.0000000000000612.
Dutta SC, Chang SC, Coffey CS, et al. Health-related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. J Urol. 2002;168:164–7.
Hart S, Skinner EC, Meyerowitz BE, et al. Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch. J Urol. 1999;162:77–81.
Forner DM, Lampe B. Ileal conduit and continent ileocecal pouch for patients undergoing pelvic exenteration: comparison of complications and quality of life. Int J Gynecol Cancer. 2011;21:403–8.
Gerharz EW, Mansson A, Hunt S, et al. Quality of life after cystectomy and urinary diversion: an evidence-based analysis. J Urol. 2005;174:1729–36.
Chiva LM, Lapuente F, Nunez C, Ramirez PT. Ileal orthotopic neobladder after pelvic exenteration for cervical cancer. Gynecol Oncol. 2009;113:47–51.
Goldberg GL, Sukumvanich P, Einstein MH, et al. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987–2003). Gynecol Oncol. 2006;101:261–8.
Smith HO, Genesen MC, Runowicz CD, et al. The rectus abdominis myocutaneous flap: modifications, complications, and sexual function. Cancer. 1998;83:510–20.
Ratliff CR, Gershenson DM, Morris M, et al. Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration. Cancer. 1996;78:2229–35.
Corney RH, Crowther ME, Everett H, Howells A, Shepherd JH. Psychosexual dysfunction in women with gynaecological cancer following radical pelvic surgery. Br J Obstet Gynaecol. 1993;100:73–8.
Andersen BL, Hacker NF. Psychosexual adjustment following pelvic exenteration. Obstet Gynecol. 1983:61:331–8.
Krouse R, Grant M, Ferrell B, et al. Quality of life outcomes in 599 cancer and non-cancer patients with colostomies. J Surg Res. 2007:138:79–87.
Watson PG. The effects of short-term postoperative counseling on cancer/ostomy patients. Cancer Nurs. 1983;6:21–9.
Pomel C, Rouzier R, Pocard M, et al. Laparoscopic total pelvic exenteration for cervical cancer relapse. Gynecol Oncol. 2003;91:616–8.
Puntambekar S, Sharma V, Jamkar AV, Gadkari Y, Joshi G, Puntambekar S, et al. Our experience of laparoscopic anterior exenteration in locally advanced cervical carcinoma. J Minim Invasive Gynecol. 2016;23:396–403.
de la GJ, Wilson SS, Behbakht K. Total pelvic exenteration with a split-thickness skin graft neovagina, continent orthotopic neobladder, and rectal reanastomosis, resulting in no external ostomies and adequate sexual function. Gynecol Oncol. 2009;115:312–3.
Acknowledgments
We thank Chantal Franco and Vincent Mauries for their valuable help in data management. This study was financially supported by the STIC (support for innovative and expensive techniques) from the Institute National du Cancer (INCA).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Martinez, A., Filleron, T., Rouanet, P. et al. Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study. Ann Surg Oncol 25, 535–541 (2018). https://doi.org/10.1245/s10434-017-6120-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-017-6120-z